SOP Guide for Pharma

Aerosol: SOP for Conducting Forced Degradation Studies on Aerosols – V 2.0

Aerosol: SOP for Conducting Forced Degradation Studies on Aerosols – V 2.0

Procedure for Conducting Forced Degradation Studies on Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/197/2025
Supersedes SOP/Aerosol/197/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the methodology for conducting forced degradation studies on aerosol products to assess their stability, degradation pathways, and potential impact on product quality.

2. Scope

This SOP applies to all aerosol formulations subjected to forced degradation conditions, including oxidative, thermal, photolytic, and hydrolytic stress conditions.

3. Responsibilities

  • Quality Control (QC) Analysts: Responsible for conducting degradation studies.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving test results.
  • Stability Study Team: Responsible for sample selection and monitoring degradation trends.
  • Regulatory Affairs Team: Responsible for ensuring compliance with ICH stability guidelines.

4. Accountability

The Quality Control Manager is accountable for ensuring accurate degradation studies and compliance with regulatory standards.

5. Procedure

5.1. Selection of Test Samples

  1. Select representative aerosol product samples for testing.
  2. Ensure each sample is appropriately labeled and stored.
  3. Record sample details in the Forced Degradation Sample Log (Annexure-1).

5.2. Forced Degradation Conditions

  1. Apply different stress conditions:
    • Oxidative stress (H₂O₂ exposure at 3% concentration).
    • Thermal stress (60°C for 10 days).
    • Photolytic stress (UV exposure for 24 hours).
    • Hydrolytic stress (moisture exposure at 75% RH).
  2. Record degradation study conditions in the Degradation Study Log
(Annexure-2).

5.3. Analytical Testing of Degraded Samples

  1. Analyze samples using HPLC, GC-MS, or spectrophotometric methods.
  2. Compare degraded samples with control samples.
  3. Document analytical results in the Degradation Analysis Report (Annexure-3).

5.4. Identification of Degradation Products

  1. Identify potential degradation by-products.
  2. Assess the toxicity and impact of degradation products on product efficacy.
  3. Record findings in the Degradation Product Identification Log (Annexure-4).

5.5. Risk Assessment and Corrective Actions

  1. Evaluate whether degradation impacts product quality.
  2. Determine if formulation modifications are required.
  3. Document corrective actions in the Degradation Study Corrective Action Log (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • HPLC: High-Performance Liquid Chromatography
  • GC-MS: Gas Chromatography-Mass Spectrometry
  • RH: Relative Humidity
  • ICH: International Council for Harmonisation

7. Documents

  1. Forced Degradation Sample Log (Annexure-1)
  2. Degradation Study Log (Annexure-2)
  3. Degradation Analysis Report (Annexure-3)
  4. Degradation Product Identification Log (Annexure-4)
  5. Degradation Study Corrective Action Log (Annexure-5)

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • ICH Q1A and Q1B Stability Guidelines
  • FDA Guidelines on Forced Degradation Studies

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Forced Degradation Sample Log

Batch No. Sample ID Stress Condition Checked By
BN-250 SPL-401 60°C for 10 Days QA Team

Annexure-2: Degradation Study Log

Sample ID Degradation Type Observation Period Reviewed By
SPL-401 Oxidation 10 Days QA Team

Annexure-3: Degradation Analysis Report

Batch No. Analysis Method Degradation % Reviewed By
BN-251 HPLC 5.2% QA Team

Annexure-4: Degradation Product Identification Log

Degradation Product Toxicity Risk Regulatory Limit Reviewed By
Impurity X Low Below Limit QA Team

Annexure-5: Degradation Study Corrective Action Log

Issue Identified Corrective Action Implementation Date Approved By
Degradation Above Limit Formulation Change 08/02/2025 Anjali Sharma

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
01/01/2025 V 2.0 Updated degradation study parameters GMP Compliance Anjali Sharma
Exit mobile version